Who invested in Adimab?
Adimab's investors include Polaris Partners, SV Life Sciences, Google Ventures, OrbiMed and Borealis Ventures.

United States · Series F startup
Funding summaryUpdated 26 Oct 2026
$40Mraised across 8 rounds since 2007, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by adimab.comSEC filing: $14M sold, first sale Mar 2012
No investor was named in the report.
Reported by masshightech.comSEC filing: $4.0M sold, first sale Nov 2010
Reported by onbiovc.comSEC filing: $8.2M sold, first sale Sept 2009
Reported by adimab.com
From Adimab's own website and the SEC filings it signed: 8 on the team.
On the board, as filediFran J. HellerMichael J. RossTerrance L. McGuireWilliam J. Maris
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Adimab's investors include Polaris Partners, SV Life Sciences, Google Ventures, OrbiMed and Borealis Ventures.
Adimab has raised $40M across 8 rounds since 2007.
Adimab's most recent round was a Series F of $14M in Apr 2012.
Its most recent round, $14M in Apr 2012, is also its largest on record.
Adimab's first round on record, in Jul 2007, was backed by Polaris Partners and SV Life Sciences.
Adimab's latest named round is a Series F, in Apr 2012.
Adimab is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.